AAN Group Meetings

Monday, April 20

8:00 AM CT (9:00 AM ET) - Darin Okuda

• Multiple Sclerosis | Director of MS & Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center

9:00 AM CT (10:00 AM ET) - Jennifer Liu

• Movement Disorder: Huntington’s Disease and Essential Tremor | Neurologist and Movement Disorders Specialist, The Brigham and Women's Hospital Inc.

10:00 AM CT (11:00 AM ET) - Peter Hedera

• Movement Disorder: Friedreich’s Ataxia, Huntington’s Disease and Essential Tremor | Professor of Neurology & Neurologist & Medical Geneticist &
  Director of the Movement Disorders Program and the Raymond Lee Lebby Endowed Chair of Parkinson's Disease Research, University of Louisville

12:00 PM CT (1:00 PM ET) - Isabella Herman

• Pediatric Epilepsy: DEEs, Dravet, LGS | Pediatric Neurologist, Boys Town National Research Hospital

1:00 PM CT (2:00 PM ET) - Chrystal Reed

• Epilepsy: Focal Onset Seizures, Azetukalner, Opakalim, Vormatrigine, RAP219 | Associate Professor of Neurology, Cedars-Sinai Health System

2:00 PM CT (3:00 PM ET) - John Hixson

• Epilepsy: Focal Onset Seizures, Azetukalner, Opakalim, Vormatrigine, RAP219 | VP Clin Development, Neurona Therapeutics Inc

Tuesday, April 21

12:00 PM CT (1:00 PM ET) - Winona Tse

• Essential Tremor: Ulixacaltamide | Professor of Neurology, Mount Sinai Health System Inc.

3:00 PM CT (4:00 PM ET) - Caleb McEntire

• Essential Tremor: Ulixacaltamide | Neurologist, Massachusetts General Hospital

Wednesday, April 22

9:00 AM CT (10:00 AM ET) - Jonathan Santoro

• Multiple Sclerosis: Fenebrutinib | Division Chief, Children's Hospital Los Angeles

11:00 AM CT (12:00 PM ET) - Shiv Saidha

• Multiple Sclerosis: Fenebrutinib | Professor of Neurology, Johns Hopkins University